https://www.selleck.au/p38-MAPK.html
p38 MAPK Inhibitors/Activators | Multiple potent, highly selective & well-cited | Selleck.Au
p38 MAPK inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies.
mapk inhibitors
https://www.selleck.co.uk/pharmacological_MAPK.html
MAPK inhibitors/activators | Selleck.Co.Uk
MAPK inhibitors used in various studies in vivo and in vitro, with complicated regulation mechanism, have been broadly applied to cancer patients.
mapk inhibitorsactivatorscouk
https://researchwith.njit.edu/en/publications/pak-signalling-drives-acquired-drug-resistance-to-mapk-inhibitors/
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas - New...
https://www.selleckchem.nl/p38-MAPK.html
p38 MAPK Remmers/Activators | Inhibitors/Activators | Meerdere potente, zeer selectieve en...
p38 MAPK-remmers (remmen doelen van signaaltransductieroutes) gebruikt voor verschillende assays, sommige zijn in klinische onderzoeken gekomen, wat nieuwe...
mapkremmersactivatorsinhibitorsmeerdere
https://pubmed.ncbi.nlm.nih.gov/25057921/
Novel small molecule XPO1/CRM1 inhibitors induce nuclear accumulation of TP53, phosphorylated MAPK...
XPO1/CRM1 is a key nuclear exporter protein that mediates translocation of numerous cellular regulatory proteins. We investigated whether XPO1 is a potential...